UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,978,500 | -43.9% | 592,921 | -4.3% | 0.00% | -100.0% |
| Q2 2023 | $7,097,808 | -52.3% | 619,355 | -16.2% | 0.00% | -50.0% |
| Q1 2023 | $14,879,000 | +97666.0% | 738,714 | +10.0% | 0.00% | 0.0% |
| Q4 2022 | $15,219 | -99.9% | 671,305 | -8.5% | 0.00% | 0.0% |
| Q3 2022 | $13,758,000 | -8.2% | 733,360 | -8.7% | 0.00% | 0.0% |
| Q2 2022 | $14,981,000 | -6.3% | 803,669 | -9.2% | 0.00% | 0.0% |
| Q1 2022 | $15,989,000 | +8.5% | 884,820 | +24.5% | 0.00% | 0.0% |
| Q4 2021 | $14,740,000 | -35.9% | 710,751 | -1.1% | 0.00% | -33.3% |
| Q3 2021 | $23,002,000 | -24.8% | 718,594 | -27.7% | 0.00% | -25.0% |
| Q2 2021 | $30,593,000 | -9.5% | 993,262 | -1.1% | 0.00% | -20.0% |
| Q1 2021 | $33,818,000 | +54.1% | 1,003,811 | +65.3% | 0.01% | +66.7% |
| Q4 2020 | $21,940,000 | +133.9% | 607,237 | +132.9% | 0.00% | +50.0% |
| Q3 2020 | $9,381,000 | +1.5% | 260,716 | +27.2% | 0.00% | 0.0% |
| Q2 2020 | $9,238,000 | +12.5% | 205,011 | +18.5% | 0.00% | 0.0% |
| Q1 2020 | $8,211,000 | +97.0% | 173,046 | +197.5% | 0.00% | +100.0% |
| Q4 2019 | $4,167,000 | -8.7% | 58,157 | -49.8% | 0.00% | 0.0% |
| Q3 2019 | $4,562,000 | -77.7% | 115,883 | -57.4% | 0.00% | -75.0% |
| Q2 2019 | $20,481,000 | -17.3% | 272,205 | -34.4% | 0.00% | -20.0% |
| Q1 2019 | $24,753,000 | +52566.0% | 414,980 | +25500.2% | 0.01% | – |
| Q4 2018 | $47,000 | -99.6% | 1,621 | -99.4% | 0.00% | -100.0% |
| Q3 2018 | $10,694,000 | +57.4% | 293,884 | +63.5% | 0.00% | +100.0% |
| Q2 2018 | $6,792,000 | +14993.3% | 179,702 | +9358.0% | 0.00% | – |
| Q1 2018 | $45,000 | -88.5% | 1,900 | -90.5% | 0.00% | – |
| Q4 2017 | $392,000 | -24.9% | 20,005 | -65.2% | 0.00% | – |
| Q3 2017 | $522,000 | +44.2% | 57,563 | -1.6% | 0.00% | – |
| Q2 2017 | $362,000 | +43.1% | 58,481 | +33.5% | 0.00% | – |
| Q1 2017 | $253,000 | +55.2% | 43,822 | +50.5% | 0.00% | – |
| Q4 2016 | $163,000 | -32.1% | 29,120 | -7.1% | 0.00% | – |
| Q3 2016 | $240,000 | +130.8% | 31,340 | +121.1% | 0.00% | – |
| Q2 2016 | $104,000 | +4.0% | 14,174 | +68.5% | 0.00% | – |
| Q1 2016 | $100,000 | -25.9% | 8,414 | +3.1% | 0.00% | – |
| Q4 2015 | $135,000 | – | 8,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |